iRhythm Holdings (IRTC) FCF Margin Growth (1y) (2016 - 2026)

iRhythm Holdings (IRTC) FCF Margin Growth (1y) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (1y) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -80.00
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 473.00
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -192.00
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -431.00
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -1,716.00
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 2,833.00
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 2,811.00
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -125.00
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 iRhythm Holdings 3.50 Bn 2.95 Bn 141.35 Mn -961.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -961.00
Dec 31, 2025 -123.00
Sep 30, 2025 709.00
Jun 30, 2025 -739.00
Mar 31, 2025 4,233.00
Dec 31, 2024 4,322.00
Sep 30, 2024 778.00
Jun 30, 2024 1,897.00
Mar 31, 2024 -1,169.00
Dec 31, 2023 -6,040.00
Sep 30, 2023 2,612.00
Jun 30, 2023 -884.00
Mar 31, 2023 1,297.00
Dec 31, 2022 1,852.00
Sep 30, 2022 -1,953.00
Jun 30, 2022 1,327.00
Mar 31, 2022 922.00
Dec 31, 2021 578.00
Sep 30, 2021 -231.00
Jun 30, 2021 1,482.00